We are offering the Pfizer–BioNTech and Moderna COVID-19 vaccines to current patients. Patients can schedule a vaccination through NYU Langone Health MyChart or the NYU Langone Health app. Learn more about the COVID-19 vaccine.
Clinical Trials and Research Studies
Phase 2
An Open-label Single-arm Single-dose Prospective Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE)
Learn MorePhase 3
An Open-label Single-arm Single-dose Prospective Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy
Learn MorePhase -1
Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
Learn MorePhase 1
A Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma
Learn More